Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Cell Reports. Medicine
|
October 14, 2025
Dendritic cell immunotherapy advances for solid tumors: Vaccination and modulation
Georgia Clayton, Elisa C Toffoli, Tanja D de Gruijl, et al.
Journal for Immunotherapy of Cancer
|
December 6, 2023
Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tumor growth, and trigger a pro-inflammatory shift in patient-derived cultures of primary and metastatic colorectal cancer
Elisa C Toffoli, Amanda A van Vliet, Henk W M Verheul, et al.
Physiological Reports
|
June 10, 2021
Effects of physical exercise on natural killer cell activity during (neo)adjuvant chemotherapy: A randomized pilot study
Elisa C Toffoli, Maike G Sweegers, Hetty J Bontkes, et al.
Cancers
|
February 12, 2021
Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response
Elisa C Toffoli, Abdolkarim Sheikhi, Yannick D Höppner, et al.
Cancers
|
November 13, 2021
Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor Receptor
Elisa C Toffoli, Abdolkarim Sheikhi, Roeland Lameris, et al.
BMC Cancer
|
November 10, 2019
Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin
Maurice J D L van der Vorst, Elisabeth C W Neefjes, Elisa C Toffoli, et al.
Oncoimmunology
|
May 7, 2026
Sex-based considerations in the choice for a TLR9 or TLR7/8 agonist to arm the sentinel lymph node in early-stage melanoma
Jessica C L Notohardjo, Elisa C Toffoli, Tara Muijlwijk, et al.
The Oncologist
|
August 1, 2020
Metoclopramide, Dexamethasone, or Palonosetron for Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting After Moderately Emetogenic Chemotherapy (MEDEA): A Randomized, Phase III, Noninferiority Trial
Maurice J D L van der Vorst, Elisa C Toffoli, Marlien Beusink, et al.
Cancer Immunology Research
|
June 27, 2023
A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell-Mediated Immune Response against EGFR-Expressing Tumors
Lisa A King, Elisa C Toffoli, Myrthe Veth, et al.
European Journal of Immunology
|
December 13, 2024
Guidelines for preparation and flow cytometry analysis of human nonlymphoid tissue DC
Diana Dudziak, Lukas Heger, William W Agace, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Cell Reports. Medicine
|
October 14, 2025
Dendritic cell immunotherapy advances for solid tumors: Vaccination and modulation
Georgia Clayton, Elisa C Toffoli, Tanja D de Gruijl, et al.
Journal for Immunotherapy of Cancer
|
December 6, 2023
Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tumor growth, and trigger a pro-inflammatory shift in patient-derived cultures of primary and metastatic colorectal cancer
Elisa C Toffoli, Amanda A van Vliet, Henk W M Verheul, et al.
Physiological Reports
|
June 10, 2021
Effects of physical exercise on natural killer cell activity during (neo)adjuvant chemotherapy: A randomized pilot study
Elisa C Toffoli, Maike G Sweegers, Hetty J Bontkes, et al.
Cancers
|
February 12, 2021
Natural Killer Cells and Anti-Cancer Therapies: Reciprocal Effects on Immune Function and Therapeutic Response
Elisa C Toffoli, Abdolkarim Sheikhi, Yannick D Höppner, et al.
Cancers
|
November 13, 2021
Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor Receptor
Elisa C Toffoli, Abdolkarim Sheikhi, Roeland Lameris, et al.
BMC Cancer
|
November 10, 2019
Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin
Maurice J D L van der Vorst, Elisabeth C W Neefjes, Elisa C Toffoli, et al.
Oncoimmunology
|
May 7, 2026
Sex-based considerations in the choice for a TLR9 or TLR7/8 agonist to arm the sentinel lymph node in early-stage melanoma
Jessica C L Notohardjo, Elisa C Toffoli, Tara Muijlwijk, et al.
The Oncologist
|
August 1, 2020
Metoclopramide, Dexamethasone, or Palonosetron for Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting After Moderately Emetogenic Chemotherapy (MEDEA): A Randomized, Phase III, Noninferiority Trial
Maurice J D L van der Vorst, Elisa C Toffoli, Marlien Beusink, et al.
Cancer Immunology Research
|
June 27, 2023
A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell-Mediated Immune Response against EGFR-Expressing Tumors
Lisa A King, Elisa C Toffoli, Myrthe Veth, et al.
European Journal of Immunology
|
December 13, 2024
Guidelines for preparation and flow cytometry analysis of human nonlymphoid tissue DC
Diana Dudziak, Lukas Heger, William W Agace, et al.
Page
of 1